Composition and methods for sterilizing dialyzers

• US 5,628,959 A
• Filed: 04/03/1995
• Issued: 05/13/1997
• Est. Priority Date: 04/03/1995
• Status: Expired due to Term

• Current Assignee: Ecolab USA Incorporated (Ecolab, Inc.)
• Original Assignee: Alcide Corp (Ecolab, Inc.)
• Inventors: Kross, Robert D.
• Primary Examiner(s): Warden, Robert J.
• Assistant Examiner(s): MCKANE, ELIZABETH L
• Application Number:
  US08/417,061
• Time in Patent Office: 771 Days
• Field of Search: 422/28, 422/37, 422/44, 134/22.13, 134/22.14, 134/22.16, 134/22.17, 134/27, 134/28, 424/661, 424/665
• US Class Current: 422/37
• CPC Class Codes: A61L 2/18 Liquid substances or solutions comprising solids or dissolved gases

Abstract

Compositions and methods are provided for sterilizing hemodialysis apparatus, particularly for reprocessing dialyzers in a manner that minimizes membrane perforations. The compositions contain a protic acid and a metal chlorite, and have a pH of at least about 2.3 and no greater than 4.2. Methods of this invention include contacting both the blood side and the dialysate side of a dialysis membrane with the composition, followed by first displacing the composition on the dialysate side with water or an aqueous alkali buffer having a pH in excess of about 6.0, such that the pH of the composition on the blood side of the dialysis membrane increases to at least about 5.0. The composition on the blood side is then displaced with saline. In a further embodiment, the composition has a pH ranging from 3.3 to 4.2, and the amount of chlorite ion in the form of chlorous acid ranges from 0.5% to 5.0% by weight of the total amount of chlorite ion in the composition. In this embodiment, the composition may be employed without associated membrane degradation by using existing hemodialysis set-up techniques, except that dialysate displacement on the dialysate side precedes saline displacement of blood side.

Claims

1. A method for disinfecting a dual-chamber hemodialyzer having a blood side and a dialysate side separated by a dialysis membrane, wherein the membrane has a blood contact surface and a dialysate contact surface, comprising:

(a) contacting a blood contact surface and a dialysate contact surface of a dialysis membrane with an effective amount of an aqueous sterilant comprising a protic acid and a metal chlorite, and wherein the sterilant has a pH ranging from about 2.3 to 4.2;

(b) replacing the sterilant in contact with the dialysate contact surface of the dialysis membrane with an aqueous solution such that the pH of the sterilant in contact with the blood contact surface of the dialysis membrane increases to at least about 5.0 to yield a pH-adjusted sterilant; and

(c) subsequently replacing the pH-adjusted sterilant in contact with the blood contact surface of the dialysis membrane with an isotonic saline solution.

2. The method of claim 1 wherein the aqueous solution contains an alkali ion.

3. The method of claim 1 wherein the sterilant in contact with the dialysate contact surface is displaced with the aqueous solution.

4. The method of claim 1 wherein the aqueous solution is a buffer solution having a pH ranging from 6.0 to 8.0.

5. The method of claim 1 wherein the metal chlorite concentration ranges from 0.01% to 1.0% by weight of the sterilant.

6. The method of claim 1 herein the metal chlorite concentration ranges from 0.01% to 0.5% by weight of the sterilant.

7. The method of claim 1 herein the metal chlorite concentration ranges from 0.02% to 0.3% by weight of the sterilant.

8. The method of claim 1 wherein the metal chlorite is sodium chlorite.

9. The method of claim 1 wherein the protic acid concentration ranges from 0.01% to 6% by weight of the sterilant.

10. The method of claim 1 where the protic acid is an organic acid.

11. The method of claim 10 wherein the organic acid has a pK ranging from 2.8 to 4.2.

12. The method of claim 10 wherein the organic acid is selected from the group consisting of citric acid, lactic acid, malic acid, tartaric acid, glycolic acid, mandelic acid, and mixtures thereof.

13. The method of claim 1 wherein the protic acid is an inorganic acid.

14. The method of claim 13 wherein the inorganic acid is selected from the group consisting of sulfuric acid, hydrochloric acid, nitric acid, phosphoric acid, and mixtures thereof.

15. The method of claim 1 wherein the protic acid is malic acid and the metal chlorite is sodium chlorite.

16. The method of claim 1 wherein the dialysis membrane is a cellulosic or cellulosic ester membrane.

17. The method of claim 1 wherein the pH of the sterilant of step (a) ranges from about 3.3 to 4.2.

18. A method for disinfecting a dual-chamber hemodialyzer having a blood side and a dialysate side separated by a dialysis membrane, wherein the membrane has a blood contact surface and a dialysate contact surface, comprising:

(a) contacting a blood contact surface and a dialysate contact surface of a dialysis membrane with an effective amount of an aqueous sterilant comprising a protic acid and a metal chlorite, and wherein the sterilant has a pH ranging from about 2.3 to 4.2;

(b) displacing the sterilant in contact with the dialysate contact surface of the dialysis membrane with an aqueous alkali ion-containing solution having a pH greater than about 6.0, such that the pH of the sterilant in contact with the blood contact surface of the dialysis membrane increases to at least about 5.0 to yield a pH-adjusted sterilant; and

(c) subsequently displacing the pH-adjusted sterilant in contact with the blood contact surface of the dialysis membrane with an isotonic saline solution.

19. The method of claim 18 wherein the aqueous alkali ion-containing solution is a buffer solution having a pH ranging from 6.0 to 8.0.

20. The method of claim 18 wherein the pH of the sterilant ranges from about 3.3 to 4.2.

21. A method for disinfecting a dual-chamber hemodialyzer having a blood side and a dialysate side separated by a dialysis membrane, wherein the membrane has a blood contact surface and a dialysate contact surface, comprising:

(a) contacting a blood contact surface and a dialysate contact surface of a dialysis membrane with an effective amount of an aqueous sterilant comprising a protic acid and a metal chlorite, wherein the sterilant has a pH ranging from about 3.3 to 4.2, and wherein the amount of chlorite ion present in the form of chlorous acid ranges from 0.5% to 5.0% by weight of the total amount of chlorite ion in the sterilant;

(b) displacing the sterilant in contact with the dialysate contact surface of the dialysis membrane with an aqueous solution, such that the pH of the sterilant in contact with the blood contact surface of the dialysis membrane increases to at least about 5.0 to yield a pH-adjusted sterilant; and

(c) subsequently displacing the pH-adjusted sterilant in contact with the blood contact surface of the dialysis membrane with an isotonic saline solution.

22. The method of claim 21 wherein the aqueous solution is unbuffered water.

23. The method of claim 21 wherein the aqueous solution is buffered isotonic dialysate.

24. The method of claim 23 wherein the buffered isotonic dialysate solution has a pH ranging from 7.2 to 7.6.

25. The method of claim 21 wherein the pH of the sterilant ranges from 3.5 to 4.2.

26. The method of claim 21 wherein the pH of the sterilant ranges from 3.6 to 4.0.